logo

News

March 2021
PUBLICATION IN SEXUALLY TRANSMITTED DISEASE

‘The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018’ [ Sex Transm Dis ]

March 2021
INTERVIEW AT 24/60 NEWS TV SHOW

Marc Brisson was interviewed on the 24/60 show hosted by Anne-Marie Dussault on Radio-Canada to explain the results of our modeling of the potential impact of a more transmissible COVID-19 variant in Quebec

February 2021
PUBLICATION IN SEXUALLY TRANSMITTED DISEASES

‘Estimated prevalence and incidence of disease-associated HPV types among 15-59-year-olds in the United States’ [ Sexually Transmitted Diseases ]

February 2021
PUBLICATION IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

‘The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada – A mathematical modeling study of surveillance data’ [ Int J Inf Dis ]

January 2021
PUBLICATION IN THE LANCET

‘Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study’ [ THE LANCET ]

January 2021
PUBLICATION IN SEXUALLY TRANSMITTED DISEASE

‘The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018’ [ Sexually Transmitted Diseases ]

January 2021
RADIO-CANADA’S SCIENTIST OF THE YEAR 2020

Marc Brisson, with his team, was chosen as Radio-Canada’s Scientist of the Year 2020 along with 3 other winners to represent mathematical modeling during the COVID-19 pandemic. The award winners were presented on January 17, 2020 on the “Années Lumière” [ Ici Première ] and Découverte [ Ici Radio-Canada ] shows. [ Radio-Canada Info ]

January 2021
PUBLICATION IN VACCINE

‘Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule’ [ Vaccine ]

January 2021
PUBLICATION IN LANCET INFECTIOUS DISEASE

‘Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study’ [ Lancet ID ]

December 2020
CONNECT 4 STUDY

Study on social contacts of Quebecers [ Dynamic vizualisation of results ]

November 2020
REPORT ON RADIO-CANADA’S DÉCOUVERTE SHOW

Radio-Canada’s Découverte show presented a report on our work on modeling COVID-19 in Quebec entitled: ‘Freiner la seconde vague’ [ Ici Radio-Canada ]

July 2020
INTERVIEW IN QUÉBEC SCIENCE

Marc Brisson is interviewed in Québec Science: ‘Faut-il craindre les vacanciers du Grand Montréal?’ [ Québec Science ]

May 2020
REPORT ON RADIO-CANADA’S DÉCOUVERTE SHOW

Radio-Canada’s Découverte show presented a report on our work on modeling COVID-19 in Quebec entitled: ‘La science des contacts’ Ici Radio-Canada ]

April 2020
INTERVIEW AT ‘RADIO-CANADA ICI PREMIÈRE’

Marc Brisson is interviewed by Claude Bernatchez about his work to model the Covid-19 in ‘Le déconfinement, un défi pour la santé publique. Entrevue avec Marc Brisson’. ici première ]

April 2020
INTERVIEW IN ‘LE DEVOIR’

Marc Brisson is interviewed about his work to model the Covid-19 epidemic and the control measures in the province of Quebec in ‘Voir par-delà le sommet de la courbe’. ledevoir ]

April 2020
INTERVIEW IN QUEBEC SCIENCE

Marc Brisson is interviewed about estimating the basic reproduction number (R0, R-naught) of Covid-19 in ‘La quête du véritable R0’. Quebec Science ]

March 2020
COVID-19 – PUBLICATION IN QUEBEC’S LE SOLEIL NEWSPAPER

Covid-19 : voici pourquoi les mesures d’éloignement social sont nécessaires’ LeSoleil ]

February 2020
WIDESPREAD MEDIA COVERAGE

WIDESPREAD MEDIA COVERAGE for our articles published in The Lancet [ Media ] Media tracking via Altmetric ]

February 2020
ASCO’S REPORTS

Our recent meta-analysis published in The Lancet has been selected for inclusion in the Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer. ASCO ]

January 2020
LANCET PUBLICATIONS

Marc Brisson is co-first author on two publications in The Lancet:

  • Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries [ Lancet ]
  • Mortality reductions and lives saved on the path to eliminating cervical cancer in 78 Low and Lower-Middle Income Countries: Comparative modelling of impact of achieving WHO targets for scaling up vaccination, cervical screening and cancer treatment services [ Lancet ]
December 2019

Our recent meta-analysis published in The Lancet ranked in the top 100 by Altmetric out of 2.7 million research outputs in 2019 Altmetric ]

December 2019

PUBLICATION IN ANNALS OF INTERNAL MEDICINE! ‘Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States’ Ann Intern Med ]

November 2019

PUBLICATION IN PAPILLOMAVIRUS RESEARCH: ‘HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control’ Papillomavirus Research ]

October 2019

LAVAL UNIVERSITY COMMUNITY REPORT. Marc Brisson’s research highlighted in Laval University’s 2018-19 community report. Report ]

October 2019

SAGE-WHO 2019. Marc Brisson and Mélanie Drolet were present. Marc Brisson presented ‘Impact of HPV Immunization Strategies in the Context of Supply Constraint’ at the Strategic Advisory Group of Experts (SAGE) Working Group on Human Papillomavirus (HPV) Immunization, held in Geneva, Switzerland, October 8-10, 2019. Meeting Agenda (PDF) ]

October 2019

WORKSHOP AT FIELDS INSTITUTE. JF Laprise took part to the workshop ‘Borders in Public Health and Mathematical Epidemiology’ held October 21-25, 2019, The Fields Institute, Toronto, Canada. Workshop schedule ]

October 2019

SMDM 2019. Dave Martin will present ‘Health and Economic Impact of HPV Testing Compared to Cytology’ at the SMDM’s 41st annual meeting held in Portland, Oregon, USA, October 20-23, 2019. SMDM 2019 ]

October 2019

ID WEEK 2019. Marc Brisson and Mélanie Drolet were present. Marc Brisson presented ‘Understanding the Science Behind Planning for Global Elimination of Cervical Cancer’, ID Week 2019 Conference, Washington, DC, USA, October 2-6, 2019. Program (PDF) ]

Août 2019

PUBLICATION IN CMAJ: ‘Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study’ CMAJ ]

August 2019

PUBLICATION IN BMC MEDICINE: ‘Guidelines for multi-model comparisons of the impact of infectious disease interventions’ Pubmed ]

August 2019

PUBLICATION IN VACCINE: ‘An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool’ Pubmed ]

August 2019

PUBLICATION IN HUMAN VACCINES & IMMUNOTHERAPEUTIC: ‘Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.’ Pubmed ]

July 2019

PUBLICATION OF A WHITE PAPER for the Single Dose HPV Vaccine Evaluation Consortium: ‘Review of the current published evidence for single-dose HPV vaccination 2nd Edition’ pdf ]

June 2019

WIDESPREAD MEDIA COVERAGE of our article published in The Lancet from local to national to international level (USA, UK, Australia, Spain, France, Norway, Denmark, Sweden, Hungary, Ireland, Argentina, Dominican Republic, Mexico, Kenya, India, Malaysia) [ Media ] Media tracking ]

June 2019

PUBLICATION IN THE LANCET! ‘Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis’ TheLancet ]

June 2019

CIHR FUNDING. Marc Brisson is a co-investigator of 3 newly CIHR funded projects :
1) Elimination of cervical cancer through vaccination and screening in high HPV prevalence settings : a mathematical modeling and cost-effectiveness study (Principal Investigator : Mathieu Maheu-Giroux) [CIHR 1] ;
2) Illiap Paanganik Qaujisarniq: Tailoring Cervical Cancer Screening Services for Inuit Women of Nunavik (Principal Investigator: Paul Brassard) [CIHR 2] ;
3) Is Ontario prepared for the return of measles? (Principal Investigator : Shelly Bolotin) [CIHR 3]

June 2019

Our team’s work was part of the evidence base that informed the ACIP vote on recommendations to extend HPV vaccination to adults over 26 years of age in the US. CDC ]

June 2019

NEW TEAM MEMBERS! Welcome to Léa Drolet Roy and Gabrielle Hudon, research assistants during the summer of 2019.

June 2019

NEW TEAM MEMBERS! Welcome to Aurélie Godbout and Patricia Lamirande, who will undertake their Master degree in Epidemiology next fall.

June 2019

SAGE-WHO WORKING GROUP MEETING. Marc Brisson presented ‘Optimal HPV vaccination strategies to prevent cervical cancer in LMIC: A mathematical modeling analysis’ at the Strategic Advisory Group of Experts (SAGE) Working Group on Human Papillomavirus (HPV) Immunization, held in Menthon St-Bernard, France, June 7, 2019.

March 2019

PUBLICATION IN THE LANCET ONCOLOGY: ‘Global elimination of cervical cancer as a public health problem’ ScienceDirect ]

February 2019

ACIP MEETING. Marc Brisson was presenting at the meeting of the Advisory Committee on Immunization Practices (ACIP): ‘Cost-Effectiveness of extending HPV vaccination above age 26 years in the U.S.’ (Atlanta, February 27) Meeting Agenda ]

December 2018

EUROGIN 2018. Marc Brisson was chair of the session ‘Two vs one dose vaccine schedules: assessing the evidence’ at EUROGIN 2018 and was invited speaker presenting ‘Population-level impact of 1-dose vaccination in Low and Middle Income Countries vs High Income Countries: Model-based analysis’. (Lisbon, December 2-5) EUROGIN 2018 – PROGRAM (PDF) ]

December 2018

EUROGIN 2018. Philippe Lemieux-Mellouki was presenting at EUROGIN 2018: ‘Impact of changes in sexual behavior on past and future trends of HPV infections and related cancers.’ (Lisbon, December 2-5) [ EUROGIN 2018 – PROGRAM (PDF) ]

October 2018

SAGE-WHO MEETING. Élodie Bénard and Dave Martin were present at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 23-25, 2018, in Geneva.

October 2018

SAGE-WHO MEETING. Marc Brisson presented at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 23-25, 2018, in Geneva. Results presented at the meeting will be used for WHO recommendations on HPV vaccination at the Global level.

October 2018

IPVC 2018. Mélanie Drolet was presenting at the 32nd International Papillomavirus Conference: ‘Reduced-dose HPV vaccination effectiveness in post-vaccination surveillance studies: using mathematical modeling to quantify the impact of biases.’ (Sydney, October 2-6)

October 2018

IPVC 2018. Marc Brisson was invited speaker at the 32nd International Papillomavirus Conference IPVC: ‘Modeling cervical cancer elimination’. He also presented: ‘The impact of HPV in the US : insights from comparing mathematical model predictions and surveillance data.’ (Sydney, October 2-6)

June 2018

PUBLICATIONS IN VALUE IN HEALTH: ‘Model Comparisons of the Effectiveness and Cost-effectiveness of Vaccination: A Systematic Review of the Literature’ ScienceDirect ]

May 2018

PUBLICATION IN VACCINE: ‘Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs’ ScienceDirect ]

March 2018

Marc Brisson is member of the newly appointed Expert Panel on the Potential Socio-economic Impacts of Antimicrobial Resistance in Canada of the Council of Canadian Academies. The goal of the panel is to assess the impact Antimicrobial Resistance has on Canadians and the health care system. scienceadvice.ca ]

February 2018

PUBLICATION IN THE INTERNATIONAL JOURNAL OF CANCER: ‘Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14 year old girls against human papillomavirus’ PubMed ]

October 2017

GRANT. Marc Brisson is one of the principal investigators on a US$ 5 million grant to 8 independent research institutions from Bill & Melinda Gates Foundation: “HPV 1-dose: Accelerating evidence and implementation”. Marc Brisson’s team is one of the Expert Groups forming the HPV One Dose Consortium.

October 2017

EUROGIN 2017. Marc Brisson was chair of the session ‘What have we learnt from population-wide HPV vaccination programs and how can it guide future vaccination policy?’ and was invited speaker presenting ‘Herd immunity effect’. (Amsterdam, October 8-11) [ EUROGIN 2017 ] Program (PDF)  ]

October 2017

EUROGIN 2017. Mélanie Drolet was invited speaker at EUROGIN 2017: ‘Evidence from post-vaccination studies in high-income countries’. (Amsterdam, October 8-11) [ EUROGIN 2017 ] Program (PDF)  ]

October 2017

EUROGIN 2017. Jean-François Laprise was presenting at EUROGIN 2017: ‘Health and economic impact of HPV testing compared to cytology: what is the optimal primary cervical cancer screening strategy for Canada?’ (Amsterdam, October 8-11) [ EUROGIN 2017 ] Program (PDF) ]

September 2017

PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: ‘The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.’ Oxford Academic ]

August 2017

PUBLICATION IN EPIDEMICS: ‘Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness’ ScienceDirect ]

August 2017

NEW TEAM MEMBER! Welcome to Guillaume Béraud (Postdoctoral Fellow)

May 2017

Marc Brisson was at the World Health Organization’s workshop ‘WHO Blueprint Plan of Action – Designing a vaccine efficacy trial during Public Health Emergencies: Towards the development of guidelines and interactive tools’. The workshop was held 1-2 May 2017 in Annecy, France.

May 2017

Marc Brisson has ranked 1st in the 2017-2018 Research Scholars Junior 2 competition of the ‘Fonds de recherche du Québec – Santé’ (FRQS).

May 2017

Marc Brisson is a principal investigator on a $ 10 million grant for the Canadian Immunization Research Network (CIRN) obtained from the Public Health Agency of Canada (PHAC) and the Canadian Institutes of Health Research (CIHR).

January 2017

PUBLICATION IN THE AMERICAN JOURNAL OF EPIDEMIOLOGY: ‘Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.’ PubMed ]

January 2017

WHO IVIR-AC MEETING. Marc Brisson participated to the meeting of the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) on ‘Ad-Hoc Expert Consultation on Clinical Trials of Non-Specific Effects of Vaccines’ at Veyrier-du-Lac, France, January 30-31, 2017

January 2017

NEW TEAM MEMBER! Welcome to Karine Larouche (Master Student in Epidemiology)

December 2016

Our team’s research work is cited in ACIP’s recommendations for ‘Use of a 2-Dose Schedule Human Papillomavirus Vaccination’ CDC ]

December 2016

SAGE-WHO MEETING. SAGE issued recommendations regarding introduction of HPV vaccination in low to middle income countries based partly on modeling results presented by Marc Brisson to SAGE in October 2016. WHO ]

November 2016

INTERVIEW IN ‘PLANÈTE F’ MAGAZINE. Marc Brisson is interviewed about vaccinating boys against HPV Planète F ]

November 2016

PUBLICATION IN LANCET PUBLIC HEALTH: ‘Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis’ [ Lancet Pub Health ] Accompanying Comment ]

October 2016

SAGE-WHO MEETING. Marc Brisson presented at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 18-20, 2016 in Geneva. Results presented at the meeting will be used for WHO recommendations on HPV vaccination at the Global level. [ Meeting Agenda ] Summary Report ]

October 2016

ACIP MEETING. ACIP voted to recommend a 2-dose HPV vaccination schedule in the US for girls and boys, based partly on modeling results presented by Marc Brisson to ACIP last June. CDC ]

October 2016

PUBLICATION IN EMERGING INFECTIOUS DISEASES: ‘Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes’ Free PMC Article ]

October 2016

PUBLICATION IN CMAJ: ‘Effect of HPV on cervical cancer screening in Alberta.’ PubMed ]

September 2016

PUBLICATION IN PLOS ONE: ‘Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review.’ Free PMC Article ]

September 2016

PUBLICATION IN THE LANCET PUBLIC HEALTH: ‘Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models’ The Lancet ]

June 2016

ACIP MEETING. Marc Brisson was presenting at the meeting of the Advisory Committee on Immunization Practices (Atlanta, June 22-23) [ Summary Report ] [ Meeting Agenda (PDF) ]

June 2016

EUROGIN 2016. Marc Brisson was chair of the session ‘The role of modeling and economics’ and was invited speaker at EUROGIN 2016: ‘What can models tell us about reduced dose schedules?’ (Salzburg, June 15-18) [ EUROGIN 2016 ] [ Program (PDF) ]

June 2016

WHO IVIR-AC MEETING. Marc Brisson attended the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) of the World Health Organization (WHO) (Geneva, May 30-June 1)

May 2016

PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: ‘Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.’ J Infectd Dis ]

May 2016

CONGRATULATIONS TO TALIA! Talía Malagón successfully defended her PhD thesis and obtained the grade of Philosophiae Doctor on May 24th, 2016.

May 2016

CONGRATS LÉA! Léa Drolet-Roy was awarded a bronze medal and a $ 1,000 university scholarship for her project VSV-EBOV contre Ebola at the Canada-Wide Science Fair (CWSF) held last May at McGill University, Montreal. Léa is a high school student coached by our team. Collège Saint-Charles Garnier ]

April 2016

Marc Brisson has been appointed full professor at Laval University.

April 2016

CONGRATS LÉA! Léa Drolet-Roy, a high school student coached by our team, was awarded a prize at the ‘Super Expo-sciences Hydro-Québec, Finale Québécoise’ 2016 for her transmission-dynamic modeling project ‘VSV-EBOV contre Ébola’. Léa will be part of the Quebec delegation at the Canada-Wide Science Fair, Montreal May 15-20, 2016. CWSF ]

March 2016

PUBLICATION IN VACCINE: ‘Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada’ PubMed ]

March 2016

PUBLICATION IN THE INTERNATIONAL JOURNAL OF CANCER: ‘Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines’ Int J Cancer ]

February 2016

PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: ‘The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine’ J Infect Dis ]

February 2016

TEACHING AT IMPERIAL COLLEGE. Marc Brisson is giving a Lecture entitled ‘Economic Evaluation: from uncertainty quantification to public health decision making’ (London, February 11, 2016)

February 2016

WHO MEETING. Marc Brisson is participating in the WHO Ad-hoc Consultation on Epidemiological Studies for Non-Specific Effects of Vaccines (Geneva, 16-17 February 2016)

February 2016

RAC 2016 AWARDS. Our proposal ranked “Outstanding” in Compute Canada’s Resource Allocation Competition (RAC) 2016 and we received a 408 core-year allocation on Colosse supercomputer at Laval University, Quebec. Compute Canada ]

January 2016

PUBLICATION IN EMERGING INFECTIOUS DISEASES: ‘Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior’ CDC ]

January 2016

NEW TEAM MEMBER! Welcome to Dave Martin (Research professional)

December 2015

Marc Brisson has joined the AIDS and Infectious Disease Network as a nominated researcher FRQS ]

November 2015

PUBLICATION IN EPIDEMIOLOGY AND INFECTION: Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus Epidemiol Infect ]

October 2015

PUBLICATION IN JNCI: ‘Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States’ JNCI ]

August 2015

CIHR FUNDING! Marc Brisson awarded a Foundation Scheme grant as Nominated PI ($ 2,384,146 over 7 years): ‘Using mathematical modeling and health economics to evaluate and optimize infectious disease prevention strategies’ CIHR ]

August 2015

PUBLICATION in Lancet Oncology: ‘Fewer than three doses of HPV vaccine’ The Lancet Oncology ]

June 2015

WHO IVIR-AC MEETING. Marc Brisson attended the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) (Geneva, June 8-12)

May 2015

CONGRATS ÉLODIE! Élodie Bénard was awarded the 1st prize for the best presentations at the ”Journée de la recherche des étudiants 2015 – Santé des populations et pratiques optimales en santé (SP-POS)”

April 2015

NEW TEAM MEMBERS! Welcome to Guillaume Gingras (Post-doctoral fellow in infectious disease modelling, PhD in Physics) and to Myriam Rousseau (Master student in Epidemiology, BSc in Actuarial Science)

March 2015

PUBLICATION IN THE LANCET ID: Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis [ The Lancet ID ] The publication was accompatnied by a comment Comment ]

January 2015

INTERVIEWS IN SCIENTIFIC AMERICAN and ‘LE FIL’ MAGAZINE about our BMJ paper (Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model BMJ 2015;350:g7584) [ Scientific American ] Le Fil ]

January 2015

Philippe Lemieux-Mellouki received a Michael Smith Foreign Study Supplement from CIHR ($ 6,000), to spend 4 months at London School of Hygiene and Tropical Medicine.

January 2015

PUBLICATION IN BMJ: Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission mode BMJ ]